PF-06730512

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-06730512, covering 2018-05-22 to 2024-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) [Phase 2]